<DOC>
	<DOC>NCT00433316</DOC>
	<brief_summary>In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.</brief_summary>
	<brief_title>Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingooopherectomy or ovarian cystectomy. The patient is not participating in other medical study at present or in the last 30 days. The patient signed on an informed consent. Age 18 years and above. ASA (American Society of Anesthesiologists) physical status grade 1 2. Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol. The patient is participating in other medical experiment at present or in the last 30 days. Acute Pelvic Inflammatory Disease. Coumadin or Aspirin treatment. ASA physical status grade 34. Age &lt; 18 years. Significant arrythmias Analgesic treatment for chronic pain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>ropivacaine</keyword>
	<keyword>laparoscopy</keyword>
	<keyword>intraperitoneal</keyword>
	<keyword>nebulization</keyword>
	<keyword>pain</keyword>
	<keyword>local analgesic</keyword>
	<keyword>gynecology</keyword>
</DOC>